Table 5 De novo mutation in the sodium channel gene SCN5A in our patient.
From: Characterization of a novel LQT3 variant with a selective efficacy of mexiletine treatment
Nucleotide Change | Amino Acid Change | Control (1,909 Korean) Count (%) | Parents (2 individuals) Count (%) |
|---|---|---|---|
c.4967C > A | p.A1656D | 0 | 0 |
